Bolt Biotherapeutics (BOLT) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to 0.49.
- Bolt Biotherapeutics' Equity Ratio fell 2509.91% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year decrease of 2509.91%. This contributed to the annual value of 0.57 for FY2024, which is 1863.58% down from last year.
- Latest data reveals that Bolt Biotherapeutics reported Equity Ratio of 0.49 as of Q3 2025, which was down 2509.91% from 0.51 recorded in Q2 2025.
- Bolt Biotherapeutics' 5-year Equity Ratio high stood at 0.93 for Q1 2021, and its period low was 0.49 during Q3 2025.
- Over the past 5 years, Bolt Biotherapeutics' median Equity Ratio value was 0.75 (recorded in 2023), while the average stood at 0.72.
- As far as peak fluctuations go, Bolt Biotherapeutics' Equity Ratio surged by 13604.7% in 2021, and later plummeted by 2559.41% in 2025.
- Bolt Biotherapeutics' Equity Ratio (Quarter) stood at 0.81 in 2021, then dropped by 7.38% to 0.75 in 2022, then dropped by 6.28% to 0.71 in 2023, then fell by 18.64% to 0.57 in 2024, then decreased by 14.05% to 0.49 in 2025.
- Its last three reported values are 0.49 in Q3 2025, 0.51 for Q2 2025, and 0.55 during Q1 2025.